BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, featuring promising progress throughout a variety of clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, more responsible substitute for therapeutic use, specif